Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer.
Sidsel C LindgaardZsófia SztupinszkiEmil MaagCarsten P HansenInna Markovna ChenAstrid Z JohansenJane P HasselbyStig Egil BojesenDorte NielsenJulia S JohansenPublished in: Cancer medicine (2022)
Our study did not reveal any new high-performing protein panels that could be used to identify patients with inoperable PDAC before surgery. The panel of 92 proteins investigated has previously been found to be applicable for diagnostic use in patients with PDAC, but it does not seem to warrant further investigation regarding resectability in the subgroup of patients with PDAC referred to surgery.